Your session is about to expire
← Back to Search
Inhaled Insulin for Type 1 Diabetes
Study Summary
This trial will compare the safety and side effects of two doses of inhaled regular insulin to a single dose of the rapid-acting insulin analog lispro.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 156 Patients • NCT02002221Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your HbA1c level is less than 10%, as confirmed by a local laboratory test. You can have one more test within a week if needed.Your fasting C-peptide level is very low.I have been using insulin injections or a pump for at least a year.I have been diagnosed with Type 1 diabetes for over a year.I am between 18 and 65 years old and have type 1 diabetes.Your body mass index (BMI) is between 18 and 28.
- Group 1: Nasal insulin 16 IU
- Group 2: Subcutaneous insulin lispro 8 U
- Group 3: Nasal insulin 8 IU
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are older adults eligible to participate in this trial?
"This medical study is recruiting patients aged 18 and older, with an upper age limit set at 65."
Who qualifies for admission to this research program?
"Those who wish to take part in this experiment should have diabetes mellitus and be between the ages of 18-65, with a maximum capacity of 20 participants."
How is Insulin typically deployed to provide relief?
"Typically, insulin is employed to ameliorate type 1 diabetes mellitus. It has been shown to help with other glycemic disorders such as type 2 diabetes mellitus, diabetic ketoacidosis and gestational diabetes too."
Have any other studies explored the efficacy of Insulin?
"Currently, 73 Insulin studies are in progress with 13 of them being in the final phase of clinical trials. These experiments span across 248 different sites and a majority take place in Sao Luis, MA."
Is Insulin administration typically secure for individuals?
"There is limited evidence in regards to the safety and efficacy of Insulin, so our team has rated it a 1 on the scale."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger